B
Balaxi Pharmaceuticals
25.06
NSE
B
Balaxi Pharmaceuticals
25.06
NSE
BALAXI Fundamentals
Company Valuation
Market Cap (₹ Cr.)
138
PE Ratio
14.60
PB Ratio
0.58
Dividend Yield
2.00%
ROE
10.82%
ROCE
12.35%
Book Value (₹)
43.12
Face Value (₹)
2.00
Analyse BALAXI with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| Domestic Institutional Investors (DII) | 0.02% | 0.02% | 0.02% | 0.02% | 2.56% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 1.74% | 0.00% |
| Public Investors | 9.82% | 16.14% | 20.03% | 22.39% | 24.41% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BALAXI Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
0
NSE Scrip Name
BALAXI
ISIN
INE618N01022



